WhatsApp
Celebrating Innovation: A Powerful Showing from Dr. Sanjay Razdan at the Society of Robotic Surgery 2025
The International Robotic Prostate Cancer Institute (IRPCI), under the leadership of renowned urologic surgeon Dr. Sanjay Razdan, had a remarkable and impactful presence at the Society of Robotic Surgery (SRS) 2025 in Strasbourg, France. This global event, hosted at the esteemed IRCAD France, brought together the world’s most respected robotic surgeons, industry pioneers, and academic thought leaders to share advancements that are reshaping the future of minimally invasive surgery.
For Dr. Razdan—internationally recognized as one of the most experienced and innovative prostate cancer surgeons in the world—SRS 2025 served as a platform to share groundbreaking insights, exchange knowledge with peers, and lead meaningful conversations that are transforming the field of robotic urologic surgery.
Expert Prostate Cancer Leadership on the Global Stage
During the week-long congress, Dr. Razdan was selected to lead multiple high-level expert panels focused on:
? Emerging Trends in Prostate Cancer
? Innovations in Prostate Therapies
? Top Urology Abstracts of the Year
Each session drew significant attendance from international urologists, surgical fellows, and industry leaders eager to learn from Dr. Razdan’s decades of experience and his pioneering surgical outcomes—especially in nerve-sparing, clipless robotic prostatectomy and Maximum Urethral Length Preservation (MULP), which have set global standards for preserving urinary continence and sexual function in prostate cancer patients.
A Family Legacy of Surgical Innovation
Adding to the impact of the week, Dr. Razdan’s daughter, Dr. Shirin Razdan, delivered an impressive and well-received presentation titled:
“Next Generation of Articulation in Robotic Renal Surgery and Beyond”
Her talk highlighted cutting-edge developments in flexible, wristed instrumentation and next-gen robotic platforms—advancements that are poised to revolutionize surgical access and precision for renal and complex urologic procedures.
The father-daughter presence at this global summit symbolized a powerful generational commitment to excellence, innovation, and leadership in the field of robotic urology.
Advancing the Field Through Global Collaboration
A special acknowledgment goes to the Society of Robotic Surgery and IRCAD France for organizing such an enriching and future-focused event. The opportunity to collaborate with thought leaders, explore new technologies, and present advanced clinical strategies allows institutions like the International Robotic Prostate Cancer Institute to stay at the forefront of global excellence in patient care.
Gratitude is also extended to industry partners such as Livsmed, whose support and advanced instrumentation platforms—such as their articulated laparoscopic and robotic tools—are accelerating what is possible in minimally invasive urology.
The Future of Robotic Prostate Cancer Surgery
As robotic surgery enters a new era of global precision and cross-border collaboration, institutions like IRPCI, guided by Dr. Sanjay Razdan, continue to set new benchmarks in patient outcomes and clinical innovation.
SRS 2025 was not just a conference—it was a confirmation that the future of robotic prostate cancer treatment is here, and Miami Robotic Surgery is at the center of it.